Skip to Main Content

Paper Details

Therapeutic Intervention with Anti-Complement Component 5 Antibody Does Not Reduce NASH but Does Attenuate Atherosclerosis and MIF Concentrations in Ldlr-/-.Leiden Mice.
Int J Mol Sci
8
2022
Anti-C5, Anti-Complement Component 5 Antibody, Atherosclerosis, Atherosclerotic lesion, BB5, Ldlr-/-.Leiden, MIF, Mice, NASH, anti-C5 antibody, atherosclerosis, cholesterol, macrophage migration inhibitory factor, mice, non-alcoholic steatohepatitis, obese, oxLDL, oxidized LDL, plasma
Author NameAffiliation
Timothy R HughesSystems Immunity Research Institute, Cardiff University
Timothy R HughesUK Dementia Research Institute Cardiff, Cardiff University
Timothy R HughesSystems Immunity Research Institute, Cardiff University
Timothy R HughesUK Dementia Research Institute Cardiff, Cardiff University
  • 1 - 4

Datasets

Release 1.2